New hope for kids with tough brain tumors: targeted treatment trial
NCT ID NCT05956821
Summary
This study is testing a new way to deliver cancer drugs directly to the brain for children and young adults whose brain tumors have come back or haven't responded to standard treatments. Doctors use a tiny catheter to deliver two existing drugs (cetuximab and bevacizumab) precisely to the tumor area through an artery, aiming to increase effectiveness while reducing side effects. The trial will first check if this repeated monthly treatment is safe, and then see how well it works at controlling tumor growth and improving survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGODENDROGLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jackson Memorial Hospital
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.